With essential tremor, life doesn’t always go the way you pictured.
As you know, essential tremor can impact everyday activities. The KINETIC 2 TRIAL is studying the potential efficacy on tremor reduction of three different doses of an investigational drug as compared to placebo. A placebo is an inactive pill that looks like the investigational drug, but contains no active medication. The safety and efficacy of investigational drugs have not been established. There is no guarantee that this drug will be approved by a health authority, such as the US Food and Drug Administration (FDA).
If you have been diagnosed with essential tremor for at least three years, you may be eligible to participate.
See if you may be eligible